These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 10527687)

  • 1. Aberrant expression of CD27 and soluble CD27 (sCD27) in HIV infection and in AIDS-associated lymphoma.
    Widney D; Gundapp G; Said JW; van der Meijden M; Bonavida B; Demidem A; Trevisan C; Taylor J; Detels R; Martínez-Maza O
    Clin Immunol; 1999 Nov; 93(2):114-23. PubMed ID: 10527687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma levels of viro-immunological markers in HIV-infected and non-infected Ethiopians: correlation with cell surface activation markers.
    Messele T; Brouwer M; Girma M; Fontanet AL; Miedema F; Hamann D; Rinke de Wit TF
    Clin Immunol; 2001 Feb; 98(2):212-9. PubMed ID: 11161977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of lymphocyte function through CD27-CD70 interactions.
    Lens SM; Tesselaar K; van Oers MH; van Lier RA
    Semin Immunol; 1998 Dec; 10(6):491-9. PubMed ID: 9826582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble CD27 induces IgG production through activation of antigen-primed B cells.
    Dang LV; Nilsson A; Ingelman-Sundberg H; Cagigi A; Gelinck LB; Titanji K; De Milito A; Grutzmeier S; Hedlund J; Kroon FP; Chiodi F
    J Intern Med; 2012 Mar; 271(3):282-93. PubMed ID: 21917027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased level of stromal cell-derived factor-1 mRNA in peripheral blood mononuclear cells from children with AIDS-related lymphoma.
    Sei S; O'Neill DP; Stewart SK; Yang Q; Kumagai M; Boler AM; Adde MA; Zwerski SL; Wood LV; Venzon DJ; Magrath IT
    Cancer Res; 2001 Jul; 61(13):5028-37. PubMed ID: 11431337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metalloprotease inhibitors block release of soluble CD27 and enhance the immune stimulatory activity of chronic lymphocytic leukemia cells.
    Kato K; Chu P; Takahashi S; Hamada H; Kipps TJ
    Exp Hematol; 2007 Mar; 35(3):434-42. PubMed ID: 17309824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased levels of soluble CD27 in the cerebrospinal fluid are not diagnostic for leptomeningeal involvement by lymphoid malignancies.
    van den Bent MJ; Lamers CH; van 't Veer MB; Sillevis Smitt PA; Bolhuis RL; Gratama JW
    Ann Hematol; 2002 Apr; 81(4):187-91. PubMed ID: 11976819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered distribution of natural killer cell subsets identified by CD56, CD27 and CD70 in primary and chronic human immunodeficiency virus-1 infection.
    Titanji K; Sammicheli S; De Milito A; Mantegani P; Fortis C; Berg L; Kärre K; Travi G; Tassandin C; Lopalco L; Rethi B; Tambussi G; Chiodi F
    Immunology; 2008 Feb; 123(2):164-70. PubMed ID: 17627773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of CD27-CD70 on early B cell progenitors in the bone marrow: implication for diagnosis and therapy of childhood ALL.
    Nilsson A; de Milito A; Mowafi F; Winberg G; Björk O; Wolpert EZ; Chiodi F
    Exp Hematol; 2005 Dec; 33(12):1500-7. PubMed ID: 16338493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD27 in B-cell chronic lymphocytic leukemia. Cellular expression, serum release and correlation with other soluble molecules belonging to nerve growth factor receptors (NGFr) superfamily.
    Molica S; Vitelli G; Levato D; Crispino G; Dell'Olio M; Dattilo A; Matera R; Gandolfo GM; Musto P
    Haematologica; 1998 May; 83(5):398-402. PubMed ID: 9658722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of hypergammaglobulinemia by HIV infection: circulating memory B-cell reduction with plasmacytosis.
    Nagase H; Agematsu K; Kitano K; Takamoto M; Okubo Y; Komiyama A; Sugane K
    Clin Immunol; 2001 Aug; 100(2):250-9. PubMed ID: 11465955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High levels of serum soluble CD27 correlated with renal dysfunction.
    Nakatsuji T
    Clin Exp Med; 2003 Feb; 2(4):192-6. PubMed ID: 12624711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the human CD27 ligand, a novel member of the TNF gene family.
    Hintzen RQ; Lens SM; Beckmann MP; Goodwin RG; Lynch D; van Lier RA
    J Immunol; 1994 Feb; 152(4):1762-73. PubMed ID: 8120385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal B cell differentiation in primary Sjögren's syndrome results in a depressed percentage of circulating memory B cells and elevated levels of soluble CD27 that correlate with Serum IgG concentration.
    Bohnhorst JØ; Bjørgan MB; Thoen JE; Jonsson R; Natvig JB; Thompson KM
    Clin Immunol; 2002 Apr; 103(1):79-88. PubMed ID: 11987988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated expression of activation induced cytidine deaminase in peripheral blood mononuclear cells precedes AIDS-NHL diagnosis.
    Epeldegui M; Breen EC; Hung YP; Boscardin WJ; Detels R; Martínez-Maza O
    AIDS; 2007 Nov; 21(17):2265-70. PubMed ID: 18090274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A soluble form of the human T cell differentiation antigen CD27 is released after triggering of the TCR/CD3 complex.
    Hintzen RQ; de Jong R; Hack CE; Chamuleau M; de Vries EF; ten Berge IJ; Borst J; van Lier RA
    J Immunol; 1991 Jul; 147(1):29-35. PubMed ID: 1646845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of zidovudine on B lymphocyte activation.
    Widney D; Yawetz S; van der Meyden M; Miles SA; Kishimoto T; Martínez-Maza O
    Cell Immunol; 1994 Oct; 158(1):140-56. PubMed ID: 8087861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of potent antiretroviral therapy on the immune activation marker soluble CD27 in patients infected with HIV-1 subtypes A-D.
    Atlas A; Thanh Ha TT; Lindström A; Nilsson A; Alaeus A; Chiodi F; De Milito A
    J Med Virol; 2004 Mar; 72(3):345-51. PubMed ID: 14748056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of CD27 in T cell immune response. Analysis by recombinant soluble CD27.
    Agematsu K; Kobata T; Sugita K; Freeman GJ; Beckmann MP; Schlossman SF; Morimoto C
    J Immunol; 1994 Aug; 153(4):1421-9. PubMed ID: 8046222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotype and function of human B cells expressing CD70 (CD27 ligand).
    Lens SM; de Jong R; Hooibrink B; Koopman G; Pals ST; van Oers MH; van Lier RA
    Eur J Immunol; 1996 Dec; 26(12):2964-71. PubMed ID: 8977292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.